BioCentury
ARTICLE | Company News

Blackfield, AstraZeneca deal

July 15, 2013 7:00 AM UTC

Blackfield will use its genomics technologies and computational biology capabilities to validate preclinical models for an undisclosed cancer program from AstraZeneca. The companies could not be reach...